celecoxib has been researched along with osteoprotegerin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koyama, Y; Kuwabara, A; Maeno, M; Mitsui, N; Sanuki, R; Shimizu, N; Shionome, C; Suzuki, N; Zhang, F | 1 |
| Alvarez-Soria, MA; Herrero-Beaumont, G; Largo, R; Moreno-Rubio, J; Tardio, L | 1 |
| Aida, Y; Honda, K; Maeno, M; Matsumura, H; Namba, A; Suzuki, N; Tanaka, H; Watanabe, Y | 1 |
| Balbontín-Ayala, F; Cañigral, A; Carlos, Fd; Cobo, T; Fernández-González, FJ; Fernández-Vázquez, JP; Gonzalo-Orden, JM; Sánchez-Lasheras, F; Vega, JA | 1 |
| Goswami, S; Sharma-Walia, N | 1 |
1 review(s) available for celecoxib and osteoprotegerin
| Article | Year |
|---|---|
Experimental evidence of pharmacological management of anchorage in Orthodontics: A systematic review.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Antioxidants; Bone Remodeling; Celecoxib; Clodronic Acid; Diclofenac; Diphosphonates; Humans; Imidazoles; Interferon-gamma; Isoxazoles; Lactones; Mice; Orthodontic Anchorage Procedures; Osteoclasts; Osteoprotegerin; Pamidronate; Rats; Resveratrol; Stilbenes; Sulfones; Tooth Mobility; Tooth Movement Techniques; Zoledronic Acid | 2015 |
1 trial(s) available for celecoxib and osteoprotegerin
| Article | Year |
|---|---|
Nonsteroidal antiinflammatory drugs and prostaglandin E(2) modulate the synthesis of osteoprotegerin and RANKL in the cartilage of patients with severe knee osteoarthritis.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cells, Cultured; Chondrocytes; Cyclooxygenase 2 Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Gene Expression; Humans; Immunohistochemistry; Osteoarthritis, Knee; Osteoprotegerin; Pyrazoles; RANK Ligand; Receptors, Prostaglandin E; Severity of Illness Index; Signal Transduction; Sulfonamides | 2010 |
3 other study(ies) available for celecoxib and osteoprotegerin
| Article | Year |
|---|---|
Compressive force induces osteoclast differentiation via prostaglandin E(2) production in MC3T3-E1 cells.
Topics: 3T3 Cells; Acid Phosphatase; Alkaline Phosphatase; Animals; Celecoxib; Cell Differentiation; Culture Media, Conditioned; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Gene Expression; Isoenzymes; Macrophage Colony-Stimulating Factor; Macrophages; Mice; Osteoclasts; Osteoprotegerin; Pyrazoles; RANK Ligand; Skull; Stress, Mechanical; Sulfonamides; Tartrate-Resistant Acid Phosphatase | 2010 |
IL-1beta suppresses the formation of osteoclasts by increasing OPG production via an autocrine mechanism involving celecoxib-related prostaglandins in chondrocytes.
Topics: Animals; Autocrine Communication; Base Sequence; Celecoxib; Cell Differentiation; Cell Line; Cells, Cultured; Chondrocytes; Culture Media, Conditioned; Dinoprostone; DNA Primers; Gene Expression; Humans; Inflammation Mediators; Interleukin-1beta; Macrophage Colony-Stimulating Factor; Mice; Osteoclasts; Osteoprotegerin; Prostaglandins; Pyrazoles; RANK Ligand; Sulfonamides | 2009 |
Crosstalk between osteoprotegerin (OPG), fatty acid synthase (FASN) and, cycloxygenase-2 (COX-2) in breast cancer: implications in carcinogenesis.
Topics: 4-Butyrolactone; Breast Neoplasms; Carcinogenesis; Caspase 9; Celecoxib; Cell Line, Tumor; Cyclooxygenase 2 Inhibitors; Fatty Acid Synthases; Female; Humans; Lipid Droplets; Lipid Metabolism; Molecular Targeted Therapy; Osteoprotegerin; Protein Binding; Receptor Cross-Talk; Signal Transduction; Tumor Microenvironment | 2016 |